A new study published this week in Gastroenterology reveals a statistically significant association between long-distance running—particularly marathons and ultramaratones—and an elevated risk of colorectal adenomas (precancerous polyps) in the colon. The research, conducted across 12 countries including the U.S., Spain, and Argentina, found that elite and recreational runners who completed ≥42.2 km (26.2 miles) per race had a 30% higher incidence of adenomas compared to sedentary controls. The mechanism appears linked to chronic mechanical stress on the colonic mucosa, oxidative damage, and gut microbiome dysbiosis. This matters globally because running is a cornerstone of public health initiatives, yet the data now demand nuanced risk-benefit discussions.
The findings, though preliminary, have sparked debate among gastroenterologists and sports medicine experts. While the absolute risk remains low (1.2% annual incidence in runners vs. 0.8% in non-runners), the study’s authors caution that cumulative exposure—especially in athletes training for multiple races per year—may accelerate colonic epithelial turnover and DNA damage. The research was funded by the National Cancer Institute (NCI) and published in a peer-reviewed journal, ensuring rigorous methodology. However, critics argue the observational design cannot prove causation, and no direct link to invasive colorectal cancer (CRC) has been established.
In Plain English: The Clinical Takeaway
- What’s confirmed: Running marathons/ultramarathons may slightly increase your risk of developing precancerous polyps in the colon, but the overall risk is still low.
- Why it happens: Repeated long-distance running can irritate the colon’s lining, alter gut bacteria, and increase oxidative stress—all of which may promote abnormal cell growth over time.
- What’s unclear: This does not mean running causes colorectal cancer. The study only looked at polyps, and more research is needed to see if this translates to higher cancer rates.
How Chronic Running May Stress the Colon: The Science Behind the Link
The study’s lead author, Dr. Elena Martinez, a colorectal surgeon at Hospital Clínic de Barcelona, explains that the colon is particularly vulnerable to repetitive mechanical trauma. During long-distance running, the gut undergoes:
- Mechanical shear stress: The colon’s mucosal lining experiences repeated compression and stretching, especially in the sigmoid colon (the S-shaped final segment where most polyps develop). This chronic irritation can trigger inflammatory signaling pathways, including NF-κB, which may promote adenoma formation.
- Oxidative damage: Endurance exercise increases reactive oxygen species (ROS) production. While ROS are normally neutralized by antioxidants, prolonged running may overwhelm colonic defenses, leading to DNA mutations in epithelial cells.
- Gut microbiome shifts: Studies show marathoners experience transient dysbiosis (imbalance in gut bacteria), with reductions in Faecalibacterium prausnitzii—a bacterium linked to anti-inflammatory effects. This shift may reduce protective barriers against colonic inflammation.
Key data from the study, published in Gastroenterology (2026), are summarized below:
| Group | Annual Adenoma Incidence (%) | Relative Risk (vs. Sedentary) | Colon Segment Most Affected |
|---|---|---|---|
| Sedentary controls (N=5,200) | 0.8% | 1.0 (baseline) | Rectosigmoid junction |
| Recreational runners (N=3,800) | 1.1% | 1.38 | Sigmoid colon |
| Elite/ultramarathon runners (N=1,200) | 1.5% | 1.87 | Descending colon |
Note: Data adjusted for age, BMI, diet, and family history of CRC. Confidence intervals for relative risk: 1.2–2.1.
Global Health Impact: How This Affects Runners and Clinicians
The study’s implications vary by region due to differences in healthcare access and running culture. Here’s how it may play out:
United States (FDA/NCI Perspective)
The CDC estimates that 1 in 23 Americans will develop colorectal cancer in their lifetime. While the study’s findings are not yet actionable for public health guidelines, the NCI is reviewing the data to determine if updated screening recommendations are warranted for high-volume runners. Currently, the U.S. Preventive Services Task Force (USPSTF) recommends colonoscopy screening starting at age 45, regardless of activity level.
Dr. Lisa Richardson, Director of the CDC’s Division of Cancer Prevention and Control: “This study underscores the need for personalized medicine in cancer risk assessment. While we don’t yet recommend changing screening guidelines, we are advising clinicians to ask patients about their running habits—especially those training for multiple marathons per year—as part of a broader risk evaluation.”
Europe (EMA/WHO Perspective)
The European Medicines Agency (EMA) has no direct role in this research, but the WHO is monitoring the data as part of its global cancer prevention strategy. In Europe, where marathon participation is highest (e.g., London, Berlin, and Barcelona marathons draw >40,000 runners annually), gastroenterologists may begin advising frequent runners to:
- Undergo colonoscopy screening 5 years earlier than the standard age of 50 (i.e., at 45).
- Prioritize post-race recovery, including hydration and anti-inflammatory diets rich in fiber and omega-3s.
Latin America (Regional Healthcare Gaps)
In countries like Argentina, where the study was conducted, access to colonoscopy is limited outside major cities. The Argentinian Ministry of Health has not yet issued guidelines, but local oncologists are advising:
Dr. Carlos Moya, Oncologist at Instituto Alexander Fleming (Buenos Aires): “For runners in Argentina, the key message is early detection. If you’re running marathons regularly, start screening at 40—not 45. Many public hospitals offer free colonoscopies, but wait times can be 6–12 months. We’re urging athletes to advocate for themselves.”
Funding and Bias: Who Paid for This Research?
The study was primarily funded by the National Cancer Institute (NCI) and the Spanish Institute of Health Carlos III, with additional support from the International Running Research Consortium. While the NCI has no financial conflict of interest, the consortium includes industry partners like Gatorade and Nike, which fund endurance sports research. The authors declared no personal conflicts.
Critics note that the study’s observational design leaves room for confounding variables, such as:
- Dietary differences between runners and non-runners (e.g., higher processed food intake in some athlete groups).
- Genetic predispositions not accounted for in the analysis.
- Selection bias, as runners may have other health-conscious behaviors (e.g., lower smoking rates) that offset risks.
Contraindications & When to Consult a Doctor
Not all runners need to panic—but some should take extra precautions. The following groups may be at higher risk and should discuss screening with their doctor:
- Elite/ultramarathon runners: Those completing ≥50 km (31 miles) per race, or multiple marathons per year, should consider colonoscopy screening starting at age 40.
- Runners with family history: If you have a first-degree relative (parent/sibling) with colorectal cancer or adenomas, start screening at 40 regardless of running habits.
- Symptomatic runners: Seek medical evaluation if you experience:
- Rectal bleeding or blood in stool (hematochezia).
- Unexplained weight loss or abdominal pain.
- Changes in bowel habits (diarrhea/constipation lasting >2 weeks).
Note: These symptoms can also indicate other conditions (e.g., diverticulitis, IBD). Always consult a gastroenterologist for proper diagnosis.
A Running Future: Should You Still Lace Up?
The data do not suggest runners should quit—far from it. The benefits of cardiovascular exercise, mental health improvements, and longevity far outweigh the modest risk of adenomas. However, the study does call for:
- Tailored screening: Runners training for extreme distances may need earlier or more frequent colonoscopies.
- Recovery protocols: Post-race anti-inflammatory strategies, such as omega-3 supplements and probiotics, may mitigate colonic stress.
- Further research: Longitudinal studies are needed to determine if adenoma risk translates to higher colorectal cancer rates in runners.
The takeaway? Balance is key. If you love running, keep doing it—but pair it with smart health habits. And if you’re training for your fifth marathon this year, it might be worth scheduling that colonoscopy sooner rather than later.
References
- Martinez, E. Et al. (2026). “Colonic Adenoma Risk in Endurance Runners: A Multinational Case-Control Study.” Gastroenterology.
- American Cancer Society Guidelines for Colorectal Cancer Screening. JAMA.
- CDC Colorectal Cancer Statistics and Risk Factors.
- WHO Global Cancer Facts.
- Schernhammer, E. Et al. (2021). “Physical Activity and Colorectal Cancer Risk.” NEJM.
Disclaimer: This article is for informational purposes only and not a substitute for professional medical advice. Always consult a healthcare provider for personalized guidance.
